Article Data

  • Views 643
  • Dowloads 140

Original Research

Open Access

Alisma orientale extract inhibits cell proliferation by promoting oxidative stress and apoptosis in prostate cancer cells

  • Junwei Xu1
  • Ning Qin2,*,
  • Wenbo Jiang3
  • Tao Chen1

1Department of Traditional Chinese Medicine, Affiliated Hospital of Nantong University, 226001 Nantong, Jiangsu, China

2Department of Medical Nursing Teaching and Research, Nantong Health College of Jiangsu Province, 226001 Nantong, Jiangsu, China

3Department of Cardiovascular Medicine, Suqian Hospital of TCM, 223800 Suqian, Jiangsu, China

DOI: 10.22514/jomh.2023.122 Vol.19,Issue 11,November 2023 pp.109-115

Submitted: 26 August 2023 Accepted: 20 October 2023

Published: 30 November 2023

*Corresponding Author(s): Ning Qin E-mail: qinning1635@163.com

Abstract

Prostate cancer is a prevalent malignancy in men, necessitating the development of more effective treatment drugs. Alisma is commonly used in clinical settings for various ailments, including tumors. However, its mechanism of action in prostate cancer cells remains unclear. This study aimed to clarify the effects of Alisma orientale extract (AOE) on prostate cancer. Our results showed that AOE inhibited prostate cancer cell growth and induced apoptosis while promoting oxidative stress. Mechanistically, AOE modulated the p38/nuclear factor kappa-B (NF-κB) pathway to inhibit prostate cancer progression. Taken together, these findings suggest that AOE could serve as a potential treatment for prostate cancer.


Keywords

Prostate cancer; Alisma orientale extract (AOE); Apoptosis; Oxidative stress; p38/NF-κB pathway


Cite and Share

Junwei Xu,Ning Qin,Wenbo Jiang,Tao Chen. Alisma orientale extract inhibits cell proliferation by promoting oxidative stress and apoptosis in prostate cancer cells. Journal of Men's Health. 2023. 19(11);109-115.

References

[1] Gómez Rivas J, Fernandez L, Abad-Lopez P, Moreno-Sierra J. Androgen deprivation therapy in localized prostate cancer. Current status and future trends. Actas UrolóGicas EspañOlas. 2023; 47: 398–407.

[2] Tani M, Hayashi Y, Miki A, Wakita T, Horibe Y, Kakuta Y, et al. A case of abiraterone acetate withdrawal syndrome after initiation of upfront abiraterone therapy for high-risk prostate cancer. IJU Case Reports. 2023; 6: 282–285.

[3] Wang Z, Zhang Y, Deng Q, Zhang J, Wang X, Liang H. Integrative analysis of androgen receptor interactors aberrations and associated prognostic significance in prostate cancer. Urology Journal. 2023; 20: 318–328.

[4] Talvitie AM, Ojala H, Tammela T, Pietilä I. Prostate cancer-related sexual dysfunction—the significance of social relations in men’s reconstructions of masculinity. To be published in Culture, Health & Sexuality. 2023. [Preprint].

[5] Ito Y, Tanaka N. Phylogeny of Alisma (Alismataceae) revisited: implications for polyploid evolution and species delimitation. Journal of Plant Research. 2023; 136: 613–629.

[6] Wei W, Li H, Deng Y, Zheng X, Zhou Y, Xue X. The combination of alisma and atractylodes ameliorates cerebral ischaemia/reperfusion injury by negatively regulating astrocyte-derived exosomal miR-200a-3p/141-3p by targeting SIRT1. Journal of Ethnopharmacology. 2023; 313: 116597.

[7] Feng Q, Yang Y, Qiao Y, Zheng Y, Yu X, Liu F, et al. Quercetin ameliorates diabetic kidney injury by inhibiting ferroptosis via activating Nrf2/HO-1 signaling pathway. The American Journal of Chinese Medicine. 2023; 51: 997–1018.

[8] Wu Y, Wang X, Yang L, Kang S, Yan G, Han Y, et al. Therapeutic effects of alisma orientale and its active constituents on cardiovascular disease and obesity. The American Journal of Chinese Medicine. 2023; 51: 623–650.

[9] Liu R, Sun Y, Di D, Zhang X, Zhu B, Wu H. PI3K/AKT/SERBP-1 pathway regulates alisma orientalis beverage treatment of atherosclerosis in APOE−/− high-fat diet mice. Pharmaceutical biology. 2023; 61: 473–487.

[10] Kwon MJ, Kim JN, Park J, Kim YT, Lee MJ, Kim BJ. Alisma canaliculatum extract affects AGS gastric cancer cells by inducing apoptosis. international Journal of Medical Sciences. 2021; 18: 2155–2161.

[11] Choi J, Ahn SS, Lim Y, Lee YH, Shin SY. Inhibitory effect of alisma canaliculatum ethanolic extract on NF-κB-dependent CXCR3 and CXCL10 expression in TNFα-exposed MDA-MB-231 breast cancer cells. International Journal of Molecular Sciences. 2018; 19: 2607.

[12] Yoshida I, Ito C, Matsuda S, Tsuji A, Yanaka N, Yuasa K. Alisol B, a triterpene from Alismatis rhizoma (dried rhizome of Alisma orientale), inhibits melanin production in murine B16 melanoma cells. Bioscience, Biotechnology, and Biochemistry. 2017; 81: 534–540.

[13] Zhao Y, Li ETS, Wang M. Alisol B 23-acetate induces autophagic-dependent apoptosis in human colon cancer cells via ROS generation and JNK activation. Oncotarget. 2017; 8: 70239–70249.

[14] Oka S, Sakaguchi K, Hayashida M, Ito S, Kurosawa K, Urakami S. First case report of robot-assisted radical cystectomy for bladder cancer that developed after salvage radiotherapy following radical prostatectomy for prostate cancer. IJU Case Reports. 2023; 6: 310–313.

[15] Hu B, Zhang H, Zhang Y, Jin Y. A nomogram based on biparametric magnetic resonance imaging for detection of clinically significant prostate cancer in biopsy-naïve patients. Cancer Imaging. 2023; 23: 82.

[16] Ghezelayagh TS, Wu ES, Barber EL, Dao MD, Zsiros E, Urban RR, et al. Timing and duration of bevacizumab treatment and survival in patients with recurrent ovarian, fallopian tube, and peritoneal cancer: a multi-institution study. European Journal of Gynaecological Oncology. 2023; 44: 17–25.

[17] Methods in Medicine CAM. Retracted: Alisol B 23-acetate increases the antitumor effect of bufalin on liver cancer through inactivating wnt/β-catenin axis. Computational and Mathematical Methods in Medicine. 2023; 2023: 9753946.

[18] Papachristodoulou A, Heidegger I, Virk RK, Di Bernardo M, Kim JY, Laplaca C, et al. Metformin overcomes the consequences of NKX3.1 loss to suppress prostate cancer progression. To be published in European Urology. 2023. [Preprint].

[19] Yao C, Li G, Cai M, Qian Y, Wang L, Xiao L, et al. Prostate cancer downregulated SIRP-alpha modulates apoptosis and proliferation through p38-MAPK/NF-kB/COX-2 signaling. Oncology Letters. 2017; 13: 4995–5001.

[20] Park JI, Lee MG, Cho K, Park BJ, Chae KS, Byun DS, et al. Transforming growth factor-beta1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-kB, JNK, and ras signaling pathways. Oncogene. 2003; 22: 4314–4332.


Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,200 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Directory of Open Access Journals (DOAJ) DOAJ is a unique and extensive index of diverse open access journals from around the world, driven by a growing community, committed to ensuring quality content is freely available online for everyone.

SCImago The SCImago Journal & Country Rank is a publicly available portal that includes the journals and country scientific indicators developed from the information contained in the Scopus® database (Elsevier B.V.)

Publication Forum - JUFO (Federation of Finnish Learned Societies) Publication Forum is a classification of publication channels created by the Finnish scientific community to support the quality assessment of academic research.

Scopus: CiteScore 0.9 (2023) Scopus is Elsevier's abstract and citation database launched in 2004. Scopus covers nearly 36,377 titles (22,794 active titles and 13,583 Inactive titles) from approximately 11,678 publishers, of which 34,346 are peer-reviewed journals in top-level subject fields: life sciences, social sciences, physical sciences and health sciences.

Norwegian Register for Scientific Journals, Series and Publishers Search for publication channels (journals, series and publishers) in the Norwegian Register for Scientific Journals, Series and Publishers to see if they are considered as scientific. (https://kanalregister.hkdir.no/publiseringskanaler/Forside).

Submission Turnaround Time

Conferences

Top